发明名称 Potent LNA oligonucleotides for the inhibition of HIF-1A expression
摘要 Disclosed is an LNA oligonucleotide consisting of the sequence: 5'- TsGsGscsasasgscsastscscsTsGsTsa -3', Wherein a capital letter designates a beta-D-oxy-LNA nucleotide analogue, a small letter designates a 2-deoxynucleotide, and subscript "s" designates a phosphorothioate link between neighbouring nucleotides/LNA nucleotide analogues. The LNA oligonucleotides are useful for modulating the expression of hypoxia-inducible factor-la (HIF-1a). Further disclosed is the use of the oligonucleotide in the manufacture of a medicament for treating cancer, inhibiting angiogenesis, inducing apoptosis, preventing cellular proliferation, and treating an angiogenic diseases such as diabetic retinopathy, macular degeneration (ARMD), psoriasis, and rheumatoid arthritis.
申请公布号 NZ555644(A) 申请公布日期 2009.04.30
申请号 NZ20050555644 申请日期 2005.11.09
申请人 SANTARIS PHARMA A/S 发明人 RASMUSSEN, FRANK WINTHER;WESTERGAARD, MAJKEN;HANSEN, HENRIK FRYDENLUND;THRUE, CHARLOTTE ALBAEK
分类号 C12N15/113;(IPC1-7):C07H21/04;A61K31/711;A61K31/712;A61P11/06;A61P17/06;A61P19/02;A61P35/00 主分类号 C12N15/113
代理机构 代理人
主权项
地址